Leading the Charge: Tempo Selected as Title Sponsor for Atlassian Team ’25
Tempo Software, a leader in strategic portfolio management, has been selected by Atlassian as the Title Sponsor for Atlassian Team ’25 Annual User Conference. This partnership underscores Tempo’s role as a trusted Atlassian partner, delivering scalable, AI-powered solutions that enable product development leaders to drive strategic outcomes.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250128636199/en/
Tempo is Title Sponsor for Atlassian's flagship event - Team '25 (Graphic: Business Wire)
A longstanding strategic partner to Atlassian
For over 15 years, Tempo has been a cornerstone of the Atlassian Marketplace, earning countless accolades, including the prestigious Enterprise Apps Partner of the Year award awarded at the Team ‘24 event. Becoming the Title Sponsor for Team ’25 reinforces Tempo’s position, not just as a marketplace leader, but as a trusted collaborator in go-to-market efforts, shaping the future of Atlassian’s ecosystem.
Greg Laderman, Head of Global Sales at Atlassian, said, “Tempo has been an invaluable partner in helping Atlassian expand into the enterprise market, delivering scalable, secure, and well supported solutions that complement our platform and strategy for growth. Their modular approach has proven popular with customers worldwide, unseating legacy providers, and we’re excited to see what Atlassian and Tempo can achieve together in 2025 and beyond.”
Delivering strategic outcomes for enterprise organizations
As the Title Sponsor, Tempo aims to empower product development leaders to align and communicate product plans to improve ROI, satisfy changing customer demands to manage risk, and govern and audit development expenses with its strategic portfolio management solutions. This sponsorship underscores Tempo’s unique ability to meet the needs of Atlassian customers by enabling them to achieve strategic alignment and operational clarity, driving success in today’s dynamic enterprise environment.
"At Tempo, we understand that the path to strategic portfolio management is unique for every organization," said Vic Chynoweth, Chief Executive Officer at Tempo. "Our maturity-model-driven solutions empower enterprise PMOs to achieve quick wins that build confidence and drive scalable success. By enabling organizations to evolve at their own pace while aligning with global objectives, we help turn initial victories into transformative achievements. This approach has solidified our role as a trusted partner in Atlassian’s ecosystem, delivering meaningful impact for enterprise clients worldwide."
Driving innovation with AI-powered solutions
Tempo’s vision aligns seamlessly with Atlassian’s mission of enterprise growth, transitioning customers to the cloud, and operational excellence. By integrating cutting-edge AI, Tempo enhances the capabilities of the Atlassian platform to deliver smarter, more adaptive solutions.
Recent advancements in AI for time tracking, sprint performance, and portfolio management showcase Tempo’s dedication to helping teams work smarter. These innovations enable teams to align and communicate product goals, adapt to changing customer demands, and gain effective governance over development expenses. 2025 will see further developments across the Tempo and Atlassian platforms.
Team ‘25, April 8-10, in Anaheim
Team ’25 marks the beginning of an exciting year for Tempo, as the company continues to deepen its relationship with Atlassian and expand its impact on the enterprise market. As Title Sponsor, Tempo will showcase how its solutions, built on Atlassian’s powerful platform, enable product development leaders to achieve strategic clarity and operational excellence. Together, Tempo and Atlassian are set to redefine the future of enterprise planning and portfolio management in 2025 and beyond.
About Tempo Software
Tempo Software empowers companies to focus on what matters most – building great products. Tempo’s flexible and modular platform helps teams plan, execute and optimize products in alignment with the customer’s strategic business priorities. Tempo’s platform includes solutions for Strategic Portfolio Management (SPM), Project and Portfolio Management (PPM), and IT Service Management (ITSM) needs. Founded in 2009, Tempo has the support of more than 300 strategic integration partners, and serves 30,000+ customers across a wide range of industries, including one in three Fortune 500 companies.
To learn more about Tempo Software, visit www.tempo.io.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250128636199/en/
Contacts
Press Contact:
PR@tempo.io
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
iFIT Expands Global Reach with Rollout of AI Coach in 19 Countries2.6.2025 16:00:00 EEST | Press release
iFIT Inc., a global leader in connected fitness and interactive content, today announced the expansion of its iFIT AI Coach (beta) across 19 countries: Australia, Austria, Belgium, Canada, Finland, France, Germany, Ireland, Italy, Luxembourg, Mexico, Netherlands, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, and the UK. This strategic expansion brings iFIT’s intelligent, personalized fitness technology to more athletes around the globe. AI Coach is iFIT’s most advanced digital training tool to date, leveraging proprietary technology and user data to deliver hyper-personalized fitness and wellness plans. The tool adapts dynamically to users' goals, schedules, and performance, offering real-time feedback and motivation across a wide range of fitness categories—from strength and cardio to recovery and mindfulness. “Expanding iFIT AI Coach beyond the U.S. reflects our mission to make intelligent, interactive fitness more accessible around the globe,” said Bart Mueller, Chief I
12BET Makes the Shortlist at the 2025 EGR Marketing & Innovation Awards2.6.2025 15:16:00 EEST | Press release
12BET, a pioneering name in the igaming world since 2007, is honored to be shortlisted in two categories at the 2025 EGR Marketing & Innovation Awards: Sportsbook Marketing Campaign, and Marketing Team of the Year – B2C. This recognition highlights the brand’s ongoing dedication to creating meaningful and original experiences that resonate with sports audiences and digital communities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250519535436/en/ The EGR Marketing & Innovation Awards are among the most respected accolades in the online gaming industry. Held annually, the awards celebrate creativity, strategic thinking, and innovation across the sector, attracting participation from many of the world’s leading companies. For 12BET, being named a finalist is a meaningful milestone that showcases the brand’s energy, originality, and deep-rooted passion for sports culture. 12BET’s approach to creativity is rooted in connection
Adtran expands Oscilloquartz atomic clock portfolio with lower-cost optical cesium solutions for wider market adoption2.6.2025 15:00:00 EEST | Press release
Adtran today launched the latest additions to its Oscilloquartz optical cesium portfolio, expanding access to precision timing across a wider range of network environments. The new OSA 3200 SP and OSA 3250 ePRC leverage advanced optical pumping technology, offering improved holdover, simplified maintenance and a typical lifetime of 10 years. Built on the same proven platform as Adtran’s high-end cesium models, the solutions enable telecom operators, data centers, power utilities and defense networks to modernize synchronization infrastructure while lowering operational complexity and cost. The new models also address industry demand for alternatives to legacy magnetic cesium clocks that are more difficult to manage over time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530192819/en/ Adtran’s OSA 3200 SP and OSA 3250 ePRC will bring lower-cost optical pumping cesium technology to new markets and applications. “We develo
Lenovo and Bellevue University Team Up to Offer Supply Chain and Logistics Education to Deliver “Smarter Technology for All”2.6.2025 14:00:00 EEST | Press release
Lenovo, the global technology powerhouse, recognized in the top 10 in the Gartner Supply Chain Top 25, and Bellevue University, one of the nation’s top online universities, are teaming up to develop the next generation of supply chain professionals. “We believe that bringing real-world Global Supply Chain experience and learning directly into an education curriculum is precisely the optimal way to upskill the workforce of the future,” said Ben Massie, Vice President, Global Supply Chain, Lenovo. “Teaming up with Bellevue allows us to attract the right talent using the right technology and deliver on our mission to make ‘smarter technology for all’ a reality.” As a preferred higher education institution tapped to team up with Lenovo to offer supply chain short-term learning, Bellevue will leverage the breadth and depth of Lenovo’s supply chain expertise across its diverse learner and corporate partner network. Massie continued, “With a network of over 30 manufacturing sites across nine
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complement C5 Inhibitor, for Treatment of Myasthenia Gravis2.6.2025 14:00:00 EEST | Press release
ImmunAbs Inc., a clinical-stage biotech specializing in developing antibody therapeutics, today announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug (IND) application to initiate a Phase 2 clinical trial evaluating the safety and efficacy of IM-101, a novel complement C5 inhibitor, for the treatment of Myasthenia Gravis. The forthcoming multicenter, randomized, double-blind, placebo-controlled study will enroll up to 90 patients to evaluate the effectiveness and safety of monthly IM-101 dosing in relieving complement-induced symptoms in MG. “This IND approval is pivotal for us as it brings us one step closer to delivering a transformative therapy for patients with autoimmune disorders”, said Dr. Dongjo Kim, the CEO of ImmunAbs, “we believe IM-101 has the potential to deliver deeper therapeutic responses and more durable remissions in patients who have failed to achieve sustained remission with current approved treatment.” About Myasthenia Gravis
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom